Brief: Eiko Lifesciences Acquired 25.01% Stake In Reflux Pharmaceuticals
18/05/2023 14:18
May 18 (Reuters) - Eiko Lifesciences Ltd EIKO.BO :
* ACQUIRED 25.01% STAKE IN REFLUX PHARMACEUTICALS
Source text for Eikon: ID:nBSE19mJhh
Further company coverage: EIKO.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eiko Lifesciences
See all newsBrief: Eiko Lifesciences To Buy 51% Stake In SSM Formulations
Brief: Eiko Lifesciences Ltd Says Buys 51% Of SSM Formulations
Brief: Eiko Lifesciences Says Proposal To Raise Funds Via Equity, Convertible Securities, Warrants
India's Eiko Lifesciences jumps on foray into logistics business
Brief: Eiko Lifesciences Announces Strategic Diversification Into Logistics And Container Management